By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung CancerChemotherapy has been the standard treatment option for Non-Small Cell Lung Cancer (NSCLC) without actionable biomarkers. Recently, immunotherapy treatments have been added into the treatment mix. Several studies presented [...]